These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32492728)

  • 1. Transcranial Sonography Findings in Alzheimer's Disease: A New Imaging Biomarker.
    Yilmaz R; Granert O; Schäffer E; Jensen-Kondering U; Schulze S; Bartsch T; Berg D
    Ultraschall Med; 2021 Dec; 42(6):623-633. PubMed ID: 32492728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Ability of Structural Transcranial Sonography in Patients with Alzheimer's Disease.
    Rastenyte D; Matijosaitis V; Laucius O; Gleizniene R; Jesmanas S; Jureniene K
    Diagnostics (Basel); 2020 Jul; 10(7):. PubMed ID: 32664455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards validation in clinical routine: a comparative analysis of visual MTA ratings versus the automated ratio between inferior lateral ventricle and hippocampal volumes in Alzheimer's disease diagnosis.
    Wittens MMJ; Allemeersch GJ; Sima DM; Vanderhasselt T; Raeymaeckers S; Fransen E; Smeets D; de Mey J; Bjerke M; Engelborghs S
    Neuroradiology; 2024 Apr; 66(4):487-506. PubMed ID: 38240767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and reliability of the medial temporal lobe atrophy scale in a memory clinic population.
    Molinder A; Ziegelitz D; Maier SE; Eckerström C
    BMC Neurol; 2021 Jul; 21(1):289. PubMed ID: 34301202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of the medial temporal lobe atrophy scale in patients with Alzheimer's disease: a systematic review and meta-analysis.
    Park HY; Park CR; Suh CH; Shim WH; Kim SJ
    Eur Radiol; 2021 Dec; 31(12):9060-9072. PubMed ID: 34510246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Ultrasound of the Medial Temporal Lobe in Alzheimer's Disease.
    Yilmaz R; Pilotto A; Roeben B; Preische O; Suenkel U; Heinzel S; Metzger FG; Laske C; Maetzler W; Berg D
    Ultraschall Med; 2017 Jun; 38(3):294-300. PubMed ID: 27273178
    [No Abstract]   [Full Text] [Related]  

  • 7. [Correlation of muscle strength with cognitive function and medial temporal lobe atrophy in patients with mild to moderate Alzheimer's disease].
    Liu SW; Li M; Zhu JT; Zhang YC; Wu YH; Liu CF; Hu H
    Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(35):2786-2792. PubMed ID: 36124351
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of automated volumetry of the hippocampus using NeuroQuant® and visual assessment of the medial temporal lobe in Alzheimer's disease.
    Persson K; Barca ML; Cavallin L; Brækhus A; Knapskog AB; Selbæk G; Engedal K
    Acta Radiol; 2018 Aug; 59(8):997-1001. PubMed ID: 29172642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medial temporal atrophy in preclinical dementia: Visual and automated assessment during six year follow-up.
    Mårtensson G; Håkansson C; Pereira JB; Palmqvist S; Hansson O; van Westen D; Westman E
    Neuroimage Clin; 2020; 27():102310. PubMed ID: 32580125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Third ventricle width measured by transcranial ultrasound and its diagnostic value in patients with Alzheimer's disease].
    Liu SW; Xie WY; Zhang YC; Zhu JT; Liu CF; Hu H
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(13):948-953. PubMed ID: 35385967
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison between visual assessment of MTA and hippocampal volumes in an elderly, non-demented population.
    Cavallin L; Bronge L; Zhang Y; Oksengård AR; Wahlund LO; Fratiglioni L; Axelsson R
    Acta Radiol; 2012 Jun; 53(5):573-9. PubMed ID: 22593123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical use of visual medial temporal lobe atrophy cut-off scores in Alzheimer's disease: Validation in a large memory clinic population.
    Claus JJ; Staekenborg SS; Holl DC; Roorda JJ; Schuur J; Koster P; Tielkes CEM; Scheltens P
    Eur Radiol; 2017 Aug; 27(8):3147-3155. PubMed ID: 28083697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medial temporal lobe atrophy increases the specificity of cerebrospinal fluid biomarkers in Alzheimer disease with minor cerebrovascular changes.
    Zhang Y; Londos E; Minthon L; Wattmo C; Blennow K; Liu HJ; Bronge L; Aspelin P; Wahlund LO
    Acta Radiol; 2009 Jul; 50(6):674-81. PubMed ID: 19455444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study.
    Wahlund LO; Julin P; Johansson SE; Scheltens P
    J Neurol Neurosurg Psychiatry; 2000 Nov; 69(5):630-5. PubMed ID: 11032615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates.
    Scheltens P; Leys D; Barkhof F; Huglo D; Weinstein HC; Vermersch P; Kuiper M; Steinling M; Wolters EC; Valk J
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):967-72. PubMed ID: 1431963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical validity of medial temporal atrophy as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework.
    Ten Kate M; Barkhof F; Boccardi M; Visser PJ; Jack CR; Lovblad KO; Frisoni GB; Scheltens P;
    Neurobiol Aging; 2017 Apr; 52():167-182.e1. PubMed ID: 28317647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automatically computed rating scales from MRI for patients with cognitive disorders.
    Koikkalainen JR; Rhodius-Meester HFM; Frederiksen KS; Bruun M; Hasselbalch SG; Baroni M; Mecocci P; Vanninen R; Remes A; Soininen H; van Gils M; van der Flier WM; Scheltens P; Barkhof F; Erkinjuntti T; Lötjönen JMP;
    Eur Radiol; 2019 Sep; 29(9):4937-4947. PubMed ID: 30796570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population.
    Wei M; Shi J; Ni J; Zhang X; Li T; Chen Z; Zhou M; Zhang L; Tan Z; Wang Y; Tian J
    BMC Geriatr; 2019 Feb; 19(1):59. PubMed ID: 30819102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.
    Schoonenboom NS; van der Flier WM; Blankenstein MA; Bouwman FH; Van Kamp GJ; Barkhof F; Scheltens P
    Neurobiol Aging; 2008 May; 29(5):669-75. PubMed ID: 17208336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.